FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sanni Lahdenperä

Research Profile

Chemicals & Drugs

Disorders

Geographic Areas

Finland

Concepts & Ideas

Co-author Network

Publications

TOP 3
Hannele Yki-Järvinen; Leena Juurinen; Michael Alvarsson; Tord Bystedt; Ian Caldwell; Melanie Davies; Sanni Lahdenperä; Gil Nijpels; Markku Vähätalo
Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.
Hannele Yki-Järvinen; R Kauppinen-Mäkelin; Mirja Tiikkainen; M Vähätalo; H Virtamo; K Nikkilä; Timo Tulokas; S Hulme; K Hardy; S McNulty; J Hänninen; H Levänen; Sanni Lahdenperä; Rainer Lehtonen; L Ryysy
Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.
Kevin M Cooper; Mika Tuomola; Sanni Lahdenperä; Timo Lövgren; Christopher T Elliott; D Glenn Kennedy
Development and validation of dry reagent time-resolved fluoroimmunoassays for zeranol and alpha-zearalenol to assist in distinguishing zeranol abuse from Fusarium spp. toxin contamination in bovine urine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sanni Lahdenperä (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Hannele Yki-Järvinen; Leena Juurinen; Michael Alvarsson; Tord Bystedt; Ian Caldwell; Melanie Davies; Sanni Lahdenperä; Gil Nijpels; Markku Vähätalo
Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.
Diabetes care 2007;30(6):1364-9.
2006: Hannele Yki-Järvinen; R Kauppinen-Mäkelin; Mirja Tiikkainen; M Vähätalo; H Virtamo; K Nikkilä; Timo Tulokas; S Hulme; K Hardy; S McNulty; J Hänninen; H Levänen; Sanni Lahdenperä; Rainer Lehtonen; L Ryysy
Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.
Diabetologia 2006;49(3):442-51.
2002: Kevin M Cooper; Mika Tuomola; Sanni Lahdenperä; Timo Lövgren; Christopher T Elliott; D Glenn Kennedy
Development and validation of dry reagent time-resolved fluoroimmunoassays for zeranol and alpha-zearalenol to assist in distinguishing zeranol abuse from Fusarium spp. toxin contamination in bovine urine.
Food additives and contaminants 2002;19(12):1130-7.
2002: Juha Vakkilainen; Päivi Pajukanta; Rita M Cantor; Ilpo Nuotio; Sanni Lahdenperä; Kati Ylitalo; Jussi Pihlajamäki; Petri T Kovanen; Markku Laakso; Jorma S A Viikari; Leena Peltonen; Marja-Riitta Taskinen
Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia.
European journal of human genetics : EJHG 2002;10(9):547-52.
2002: Ming-Lin Liu; Kati Ylitalo; Juha Vakkilainen; Ilpo Nuotio; Miia Valkonen; Sanni Lahdenperä; Jorma Viikari; Marja-Riitta Taskinen
Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes.
Annals of medicine 2002;34(1):48-54.
2002: Mika Tuomola; Kevin M Cooper; Sanni Lahdenperä; G Andrew Baxter; Christopher T Elliott; D Glenn Kennedy; Timo Lövgren
A specificity-enhanced time-resolved fluoroimmunoassay for zeranol employing the dry reagent all-in-one-well principle.
The Analyst 2002;127(1):83-6.
2001: Mikko Syvänne; Pia Pajunen; Juhani Kahri; Sanni Lahdenperä; Christian Ehnholm; Markku S Nieminen; Marja-Riitta Taskinen
Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects.
Coronary artery disease 2001;12(2):99-106.
2000: Juha Vakkilainen; Sari Mäkimattila; Anneli Seppälä-Lindroos; Satu Vehkavaara; Sanni Lahdenperä; Per-Henrik Groop; Marja-Riitta Taskinen; Hannele Yki-Järvinen
Endothelial dysfunction in men with small LDL particles.
Circulation 2000;102(7):716-21.
1999: Robert Bergholm; Sari Mäkimattila; Miia Valkonen; Ming-Lin Liu; Sanni Lahdenperä; Marja-Riitta Taskinen; Anssi Sovijärvi; P Malmberg; Hannele Yki-Järvinen
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo.
Atherosclerosis 1999;145(2):341-9.
1999: Sari Mäkimattila; Ming-Lin Liu; Juha Vakkilainen; A Schlenzka; Sanni Lahdenperä; Mikko Syvänne; M Mäntysaari; Paula Summanen; Robert Bergholm; Marja-Riitta Taskinen; Hannele Yki-Järvinen
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
Diabetes care 1999;22(6):973-81.
1999: Ming-Lin Liu; Robert Bergholm; Sari Mäkimattila; Sanni Lahdenperä; Miia Valkonen; H Hilden; Hannele Yki-Järvinen; Marja-Riitta Taskinen
A marathon run increases the susceptibility of LDL to oxidation in vitro and modifies plasma antioxidants.
The American journal of physiology 1999;276(6 Pt 1):E1083-91.
1997: Petteri Knudsen; S Murtomäki; Marjatta Antikainen; Sonja Jaari; Sanni Lahdenperä; Christian Ehnholm; Marja-Riitta Taskinen
The Asn-291-->Ser and Ser-477-->Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia.
European journal of clinical investigation 1997;27(11):928-35.
1997: Kimmo Porkka; Ilpo Nuotio; Päivi Pajukanta; Christian Ehnholm; L Suurinkeroinen; Mikko Syvänne; Terho Lehtimäki; Anne-Tiina Lahdenkari; Sanni Lahdenperä; Kati Ylitalo; Marjatta Antikainen; Markus Perola; Olli T Raitakari; Petri T Kovanen; Jorma S A Viikari; Leena Peltonen; Marja-Riitta Taskinen
Phenotype expression in familial combined hyperlipidemia.
Atherosclerosis 1997;133(2):245-53.
1997: Olli T Raitakari; Otto Pitkänen; Terho Lehtimäki; Sanni Lahdenperä; H Iida; Seppo Ylä-Herttuala; Jukka S Luoma; K Mattila; T Nikkari; Marja-Riitta Taskinen; Jorma S A Viikari; Juhani Knuuti
In vivo low density lipoprotein oxidation relates to coronary reactivity in young men.
Journal of the American College of Cardiology 1997;30(1):97-102.
1997: Marju Tilly-Kiesi; Juhani Kahri; T Pyörälä; J Puolakka; H Luotola; M Lappi; Sanni Lahdenperä; Marja-Riitta Taskinen
Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Atherosclerosis 1997;129(2):249-59.
1997: Petteri Knudsen; Marjatta Antikainen; Mikko Uusi-Oukari; Sonja Jaari; Sanni Lahdenperä; A Bensadoun; Harald Funke; Heiko Wiebusch; Gerd Assmann; Marja-Riitta Taskinen; Christian Ehnholm
Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene.
Atherosclerosis 1997;128(2):165-74.
1996: Marja-Riitta Taskinen; J Puolakka; T Pyörälä; H Luotola; M Bjäörn; J Kääriänen; Sanni Lahdenperä; Christian Ehnholm
Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(10):1215-21.
1996: M R Taskinen; Sanni Lahdenperä; Mikko Syvänne
New insights into lipid metabolism in non-insulin-dependent diabetes mellitus.
Annals of medicine 1996;28(4):335-40.
1996: Sanni Lahdenperä; J Puolakka; T Pyörälä; H Luotola; Marja-Riitta Taskinen
Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens.
Atherosclerosis 1996;122(2):153-62.
1996: Sanni Lahdenperä; Mikko Syvänne; Juhani Kahri; Marja-Riitta Taskinen
Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
Diabetologia 1996;39(4):453-61.
1996: Petteri Knudsen; Marjatta Antikainen; Sonja Jaari; Mikko Uusi-Oukari; H Tenkanen; Sanni Lahdenperä; Juhani Kahri; Marju Tilly-Kiesi; A Bensadoun; Marja-Riitta Taskinen; Christian Ehnholm
A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression.
Journal of lipid research 1996;37(4):825-34.
1996: Mikko Syvänne; Marjatta Antikainen; Sonja Jaari; H Tenkanen; Sanni Lahdenperä; Christian Ehnholm; Marja-Riitta Taskinen
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia.
Journal of lipid research 1996;37(4):727-38.
1995: Marju Tilly-Kiesi; Q Zhang; Sonja Jaari; Juhani Kahri; Sanni Lahdenperä; Christian Ehnholm; Marja-Riitta Taskinen
ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(9):1294-306.
1995: Mikko Syvänne; M Ahola; Sanni Lahdenperä; Juhani Kahri; Tuomo Kuusi; Kari S Virtanen; Marja-Riitta Taskinen
High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease.
Journal of lipid research 1995;36(3):573-82.
1995: Petteri Knudsen; J Eriksson; Sanni Lahdenperä; Juhani Kahri; Leif Groop; Marja-Riitta Taskinen
Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.
Diabetologia 1995;38(3):344-50.
1995: Sanni Lahdenperä; Timo Sane; H Vuorinen-Markkola; Petteri Knudsen; Marja-Riitta Taskinen
LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes.
Atherosclerosis 1995;113(2):227-36.
1994: Sanni Lahdenperä; Per-Henrik Groop; Marju Tilly-Kiesi; Tuomo Kuusi; T G Elliott; Giancarlo Viberti; Marja-Riitta Taskinen
LDL subclasses in IDDM patients: relation to diabetic nephropathy.
Diabetologia 1994;37(7):681-8.
1993: Juhani Kahri; H Vuorinen-Markkola; Marju Tilly-Kiesi; Sanni Lahdenperä; Marja-Riitta Taskinen
Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
Atherosclerosis 1993;102(1):79-89.
1993: M Välimäki; Juhani Kahri; Kalevi Laitinen; Sanni Lahdenperä; Tuomo Kuusi; Christian Ehnholm; Matti Jauhiainen; J M Bard; J C Fruchart; Marja-Riitta Taskinen
High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawal.
European journal of clinical investigation 1993;23(7):406-17.
1993: Sanni Lahdenperä; Marju Tilly-Kiesi; H Vuorinen-Markkola; Tuomo Kuusi; Marja-Riitta Taskinen
Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes.
Diabetes care 1993;16(4):584-92.
1992: Marju Tilly-Kiesi; Mikko Syvänne; Tuomo Kuusi; Sanni Lahdenperä; Marja-Riitta Taskinen
Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease.
Journal of lipid research 1992;33(3):333-42.